Downregulation of ATP1A1 promotes cancer development in renal cell carcinoma

Table 3 Correlations of ATP1A1 with RCC patient’s clinical information

Clinicopathologic variables	Case number	ATP1A1 protein		P value
Clinicopathologic variables	Case number	Negative (n = 33)	Positive (n = 47)	P value
Gender
Male	44	22	22	0.079
Female	36	11	25	0.079
Age
<60	43	22	21	0.052
≥60	37	11	26	0.052
Tumor stage
I–II	70	26	44	0.038
III–IV	10	7	3	0.038
Tumor size
<100	46	17	29	0.364
≥100	34	16	18	0.364

P < 0.05 was considered statistically significant. P value was calculated using Pearson χ² test
Negative: ATP1A1-negative expression with score 0; positive: ATP1A1-positive expression with score more than 0

ISSN: 1559-0275